Hong Kong, September 14, 2024 – Axbio Inc., as a leader in next-generation clinical diagnostics and AI-driven healthcare solutions, made a significant impact at BIOHK 2024, the premier international biotechnology convention held at the Hong Kong Convention and Exhibition Centre. The event gathered global leaders, innovators, and stakeholders from the biotech and life sciences industries to explore the latest advancements and foster strategic collaborations.

Berkeley, CA – May 14, 2024 – Axbio Inc. participated in the 24th Bay Area Aging Meeting (BAAM) 2024, held at the University of California, Berkeley, reinforcing its commitment to advancing aging research and precision health. The event gathered leading experts, researchers, and industry professionals to discuss the latest breakthroughs in longevity science.

November 7th, 2023 - At the end of 2023, Axbio's core research team, published a study titled "Unraveling the Salt Tolerance of Phi29 DNA Polymerase Using a Compartmentalized Self-Replication and Microfluidics Platform1." in the Frontiers in Microbiology journal.